Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion type Assertion NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_head.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_provenance.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion evidence source_evidence_literature NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_provenance.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion SIO_000772 23861247 NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_provenance.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion wasDerivedFrom befree-20140225 NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_provenance.
- NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_assertion wasGeneratedBy ECO_0000203 NP588473.RA16d3TMLtYpOXBh0cO3cuCEa45Rg5yA5ry7CJhI1HIjM130_provenance.